HomeCompareSTJPF vs JNJ

STJPF vs JNJ: Dividend Comparison 2026

STJPF yields 1.38% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 STJPF wins by $103.00 in total portfolio value
10 years
STJPF
STJPF
● Live price
1.38%
Share price
$17.43
Annual div
$0.24
5Y div CAGR
-33%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.1K
Annual income
$2.57
Full STJPF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — STJPF vs JNJ

📍 STJPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSTJPFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, STJPF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
STJPF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

STJPF
Annual income on $10K today (after 15% tax)
$117.04/yr
After 10yr DRIP, annual income (after tax)
$2.18/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $701.43/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of STJPF + JNJ for your $10,000?

STJPF: 50%JNJ: 50%
100% JNJ50/50100% STJPF
Portfolio after 10yr
$20.1K
Annual income
$415.17/yr
Blended yield
2.07%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

STJPF
Analyst Ratings
2
Buy
2
Hold
Consensus: Buy
Altman Z
0.3
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

STJPF buys
0
JNJ buys
0
No recent congressional trades found for STJPF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSTJPFJNJ
Forward yield1.38%3.36%
Annual dividend / share$0.24$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR-33%5.8%
Portfolio after 10y$20.1K$20.0K
Annual income after 10y$2.57$827.78
Total dividends collected$277.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: STJPF vs JNJ ($10,000, DRIP)

YearSTJPF PortfolioSTJPF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,792$92.25$10,676$355.77+$116.00STJPF
2$11,610$62.34$11,407$389.39+$203.00STJPF
3$12,465$42.00$12,198$426.53+$267.00STJPF
4$13,366$28.23$13,056$467.62+$310.00STJPF
5$14,320$18.96$13,987$513.12+$333.00STJPF
6$15,335$12.72$14,998$563.56+$337.00STJPF
7$16,417$8.53$16,098$619.52+$319.00STJPF
8$17,572$5.72$17,295$681.69+$277.00STJPF
9$18,806$3.83$18,599$750.82+$207.00STJPF
10$20,125$2.57$20,022$827.78+$103.00STJPF

STJPF vs JNJ: Complete Analysis 2026

STJPFStock

St. James's Place plc is a publicly owned investment manager. The firm launches and manages equity, fixed income, and balanced mutual funds for its clients. It invests in public equity and fixed income market across the globe. The firm was formerly known as St. James's Place Capital plc. St. James's Place plc was founded in 1991 and is based in Cirencester, United Kingdom.

Full STJPF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this STJPF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

STJPF vs SCHDSTJPF vs JEPISTJPF vs OSTJPF vs KOSTJPF vs MAINSTJPF vs ABBVSTJPF vs MRKSTJPF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.